First Real-World glimpse at asthma drug before market launch
NCT ID NCT06487065
Summary
This study looked back at medical records to see how 33 patients with severe, hard-to-control asthma responded to the drug tezepelumab in real Spanish clinics. The goal was to gather the first information on how the drug worked outside of formal clinical trials, specifically for patients who received it through a special access program before it was commercially available. Researchers collected data on asthma attacks, lung function, and quality of life to understand the drug's effects in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alcázar de San Juan, Spain
-
Research Site
Almería, Spain
-
Research Site
Badajoz, Spain
-
Research Site
Bilbao, Spain
-
Research Site
Coslada, Spain
-
Research Site
Donostia / San Sebastian, Spain
-
Research Site
Fuenlabrada, Spain
-
Research Site
Gran Canaria, Spain
-
Research Site
Lugo, Spain
-
Research Site
Madrid, Spain
-
Research Site
Málaga, Spain
-
Research Site
Talavera de la Reina, Spain
-
Research Site
Torrejón de Ardoz, Spain
-
Research Site
Valencia, Spain
Conditions
Explore the condition pages connected to this study.